{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:11:10Z","timestamp":1793643070513,"version":"4.5.1"},"reference-count":47,"publisher":"Elsevier","isbn-type":[{"value":"9780323994019","type":"print"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/bs.ircmb.2022.04.008","type":"book-chapter","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T09:35:16Z","timestamp":1654248916000},"page":"159-174","source":"Crossref","is-referenced-by-count":8,"title":["Present and future of lipid nanoparticle-mRNA technology in phenylketonuria disease treatment"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.ircmb.2022.04.008_bb0010","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1038\/s41467-021-26524-0","article-title":"Improvement of a synthetic live bacterial therapeutic for phenylketonuria with biosensor-enabled enzyme engineering","volume":"12","author":"Adolfsen","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0015","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/475731","article-title":"Before it gets started: regulating translation at the 5\u2032 UTR","volume":"2012","author":"Araujo","year":"2012","journal-title":"Comp. Funct. Genomics"},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fasebj.2020.34.s1.06346","article-title":"Amino acid substitution at Phe80 of mammalian phenylalanine hydroxylase destabilizes both resting-state and activated conformations increasing the population of intermediates","volume":"34","author":"Arturo","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.biochi.2020.11.011","article-title":"Manipulation of a cation-\u03c0 sandwich reveals conformational flexibility in phenylalanine hydroxylase","volume":"183","author":"Arturo","year":"2021","journal-title":"Biochimie"},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0030","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/humu.22980","article-title":"Genetics of phenylketonuria: then and now","volume":"37","author":"Blau","year":"2016","journal-title":"Hum. Mutat."},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0035","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ymgme.2009.01.002","article-title":"Optimizing the use of sapropterin (BH(4)) in the management of phenylketonuria","volume":"96","author":"Blau","year":"2009","journal-title":"Mol. Genet. Metab."},{"issue":"636","key":"10.1016\/bs.ircmb.2022.04.008_bb0040","doi-asserted-by":"crossref","first-page":"eabl9238","DOI":"10.1126\/scitranslmed.abl9238","article-title":"In vivo prime editing of a metabolic liver disease in mice","volume":"14","author":"B\u00f6ck","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0045","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1016\/S0021-9258(17)30123-0","article-title":"The mechanism of the irreversible inhibition of rat liver phenylalanine hydroxylase due to treatment with p-chlorophenylalanine. The lack of effect on turnover of phenylalanine hydroxylase","volume":"254","author":"Chang","year":"1979","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0050","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA vaccines for infectious diseases: principles, delivery and clinical translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/bs.ircmb.2022.04.008_bb231","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0055","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ymthe.2019.03.003","article-title":"Non-viral delivery of zinc finger nuclease mRNA enables highly efficient in vivo genome editing of multiple therapeutic gene targets","volume":"27","author":"Conway","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/nu13020484","article-title":"Protein substitutes in PKU; their historical evolution","volume":"13","author":"Daly","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0065","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.ymthe.2021.04.001","article-title":"A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice","volume":"29","author":"de Alwis","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0070","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ymgme.2021.01.014","article-title":"Mesenchymal stem cell energy deficit and oxidative stress contribute to osteopenia in the Pah(enu2) classical PKU mouse","volume":"132","author":"Dobrowolski","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0075","doi-asserted-by":"crossref","first-page":"11229","DOI":"10.1073\/pnas.1902639116","article-title":"Structure of full-length human phenylalanine hydroxylase in complex with tetrahydrobiopterin","volume":"116","author":"Flydal","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0080","first-page":"57","article-title":"Living with phenylketonuria: lessons from the PKU community","volume":"17","author":"Ford","year":"2018","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0085","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1021\/bc500320j","article-title":"Promises and pitfalls of intracellular delivery of proteins","volume":"25","author":"Fu","year":"2014","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0090","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis","volume":"385","author":"Gillmore","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0095","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0100","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.coviro.2021.03.008","article-title":"Future considerations for the mRNA-lipid nanoparticle vaccine platform","volume":"48","author":"Igy\u00e1rt\u00f3","year":"2021","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0105","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ymgme.2017.06.005","article-title":"New protein structures provide an updated understanding of phenylketonuria","volume":"121","author":"Jaffe","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0110","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Karik\u00f3","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0115","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.abb.2013.03.006","article-title":"Regulation of phenylalanine hydroxylase: conformational changes upon phosphorylation detected by H\/D exchange and mass spectrometry","volume":"535","author":"Li","year":"2013","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0120","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s40265-019-01079-z","article-title":"Phenylketonuria: current treatments and future developments","volume":"79","author":"Lichter-Konecki","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0125","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13023-020-01391-y","article-title":"PKU dietary handbook to accompany PKU guidelines","volume":"15","author":"MacDonald","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0130","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/mt.2013.124","article-title":"Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeutics","volume":"21","author":"Maier","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0135","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.molmed.2014.09.003","article-title":"A critical analysis of codon optimization in human therapeutics","volume":"20","author":"Mauro","year":"2014","journal-title":"Trends Mol. Med."},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0140","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2002-3-3-reviews0004","article-title":"Untranslated regions of mRNAs","volume":"3","author":"Mignone","year":"2002","journal-title":"Genome Biol."},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0145","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrd4363","article-title":"Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies","volume":"13","author":"Mitragotri","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0150","author":"Moderna_Therapeutics_Annual_Science:Day"},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0155","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.omtn.2022.02.020","article-title":"Development of an mRNA replacement therapy for phenylketonuria","volume":"28","author":"Perez-Garcia","year":"2022","journal-title":"Mol. Ther.\u2013Nucleic Acids"},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0160","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020401118","article-title":"Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3","volume":"118","author":"Qiu","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0165","doi-asserted-by":"crossref","first-page":"E1941","DOI":"10.1073\/pnas.1619653114","article-title":"Systemic delivery of factor IX messenger RNA for protein replacement therapy","volume":"114","author":"Ramaswamy","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0170","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ymgme.2020.09.005","article-title":"A novel Pah-exon1 deleted murine model of phenylalanine hydroxylase (PAH) deficiency","volume":"131","author":"Richards","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0175","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.omtm.2019.12.004","article-title":"AAV-mediated CRISPR\/Cas9 gene editing in murine phenylketonuria","volume":"17","author":"Richards","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0180","doi-asserted-by":"crossref","first-page":"7846","DOI":"10.1021\/bi501183x","article-title":"Activation of phenylalanine hydroxylase by phenylalanine does not require binding in the active site","volume":"53","author":"Roberts","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0185","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/s41587-021-00933-4","article-title":"In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels","volume":"39","author":"Rothgangl","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0190","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/genetics\/134.4.1205","article-title":"Mouse models of human phenylketonuria","volume":"134","author":"Shedlovsky","year":"1993","journal-title":"Genetics"},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0195","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jpeds.2008.11.040","article-title":"Efficacy of sapropterin dihydrochloride in increasing phenylalanine tolerance in children with phenylketonuria: a phase III, randomized, double-blind, placebo-controlled study","volume":"154","author":"Trefz","year":"2009","journal-title":"J. Pediatr."},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0200","doi-asserted-by":"crossref","first-page":"9076","DOI":"10.3390\/ijms21239076","article-title":"E3 ubiquitin ligase APC\/CCdh1 regulation of phenylalanine hydroxylase stability and function","volume":"21","author":"Tyagi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0205","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41572-021-00267-0","article-title":"Phenylketonuria","volume":"7","author":"van Spronsen","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0210","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/s41591-018-0209-1","article-title":"Treatment of a metabolic liver disease by in vivo genome base editing in adult mice","volume":"24","author":"Villiger","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0215","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1006\/mgme.2001.3198","article-title":"Homomeric and heteromeric interactions between wild-type and mutant phenylalanine hydroxylase subunits: evaluation of two-hybrid approaches for functional analysis of mutations causing hyperphenylalaninemia","volume":"73","author":"Waters","year":"2001","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0220","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.addr.2020.06.026","article-title":"Lipid nanoparticle technology for therapeutic gene regulation in the liver","volume":"159","author":"Witzigmann","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"Suppl. 2","key":"10.1016\/bs.ircmb.2022.04.008_bb0225","first-page":"139","article-title":"The possibility for prenatal diagnosis of PKU by linkage analyses based on phenylalanine hydroxylase locus specific DNA-polymorphisms","volume":"7","author":"Woo","year":"1984","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/bs.ircmb.2022.04.008_bb0230","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.omtm.2022.01.001","article-title":"A universal strategy for AAV delivery of base editors to correct genetic point mutations in neonatal PKU mice","volume":"24","author":"Zhou","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/bs.ircmb.2022.04.008_bb9000","article-title":"Lipid nanoparticle delivers phenylalanine ammonia lyase mRNA to the liver leading to catabolism and clearance of phenylalanine in a phenylketonuria mouse model","volume":"32","author":"Ramon","year":"2022","journal-title":"Molecular Genetics and Metabolism Reports"}],"container-title":["International Review of Cell and Molecular Biology","mRNA-Based Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1937644822000533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1937644822000533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T07:07:16Z","timestamp":1753686436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1937644822000533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9780323994019"],"references-count":47,"URL":"https:\/\/doi.org\/10.1016\/bs.ircmb.2022.04.008","relation":{},"ISSN":["1937-6448"],"issn-type":[{"value":"1937-6448","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}